How Ozempic Has Forever Changed How Much People Spend on Food, According to a New Cornell University Study
Ozempic doesn’t just reduce weight. Research shows GLP-1s also changes how much people spend on food, and the types of food they buy.
According to a survey conducted by KFF Polling, about 12 percent of Americans have tried Ozempic, Wegovy, or other GLP-1 drugs. (If you aren’t familiar, GLP-1 agonists are a class of prescription drugs used to treat diabetes and prevent heart attacks and strokes, and are also used for weight loss.) The same survey found that 6 percent say they are currently taking a GLP-1. That works out to around seven million people currently taking a GLP-1, which is a lot.
